Moderna Inc. Stock Falls 17.6%, Underperforms Peers
Dow Jones2026/10/22 20:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Moderna Inc. tumbled 17.6% to $202.63 on what proved to be an all-around dismal trading session for the stock market, with the Dow Jones Industrial Average remaining mostly unchanged at 52,867.98 and the NASDAQ Composite Index falling 2.6% to 26,008.86.
The stock's fall snapped a three-day winning streak.
Moderna Inc. closed 20.4% below its 52-week high of $254.48, which the company reached on October 21st.
The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 3.8% to $267.61, Pfizer Inc. rose 1.9% to $30.42, and Gilead Sciences Inc. rose 2.36% to $157.19.
Trading volume totaled 49.5 million, compared to the 50-day average of 23.7 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 22, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
A wallet address sold 1.44 million TRX via SunSwap in exchange for 460,000 USDT.
Data: Whales have cumulatively withdrawn approximately 13.4 million USDT from a certain exchange.
Ripple Joins BlackRock, Standard Chartered in New Tokenization Report
Who is Satoshi Nakamoto? New Grok AI Study Tests Multiple Theories
Crypto prices
More
